Late development of resistance to BRAF/MEK inhibitors in malignant melanoma: a case report

被引：0
|
作者：
Adam, C. [1 ]
Meier, F. [1 ]
Garzarolli, M. [1 ]
机构：
[1] Uniklinikum Dresden, Dresden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP085
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] The "SWOT" of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
    Nissan, Moriah H.
    Solit, David B.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (06) : 479 - 487
  • [32] The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both?
    Moriah H. Nissan
    David B. Solit
    Current Oncology Reports, 2011, 13 : 479 - 487
  • [33] Case Report: Successful Use of BRAF/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma
    Wu, Ze-Pei
    Wang, Yue-Long
    Wang, Li-Chong
    Liu, Zhi-Yong
    Fan, Rang -Rang
    Zan, Xin
    Liang, Rui-Chao
    Yang, Jin-Long
    Zhou, Liang-Xue
    Xu, Jian-Guo
    WORLD NEUROSURGERY, 2023, 180 : E117 - E126
  • [34] Patient with stage IV melanoma with BRAF mutation - immunotherapy or BRAF and MEK inhibitors?
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (02): : 100 - 103
  • [35] Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma
    Pape, Katrin
    Protopapa, Maria
    Schraad, Muriel
    Steffen, Falk
    Zipp, Frauke
    Bittner, Stefan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
    Sanchez, Jaquelyn N.
    Wang, Ton
    Cohen, Mark S.
    DRUGS, 2018, 78 (05) : 549 - 566
  • [37] BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
    Jaquelyn N. Sanchez
    Ton Wang
    Mark S. Cohen
    Drugs, 2018, 78 : 549 - 566
  • [38] The role of beta-catenin in the therapy resistance of malignant melanoma to BRAF inhibitors
    Makino, E.
    Niessner, H.
    Krueger, M.
    Meier, F.
    Schittek, B.
    Sinnberg, T.
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (03) : E39 - E39
  • [39] Response and resistance to BRAF inhibitors in melanoma
    Flaherty, K. T.
    ANNALS OF ONCOLOGY, 2011, 22 : 14 - 14
  • [40] TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors
    de Oliveira, Erica Aparecida
    Chauhan, Jagat
    da Silva, Julia Rezende
    da Costa Carvalho, Larissa Anastacio
    Dias, Diogo
    de Carvalho, Danielle Goncalves
    Masao Watanabe, Luis Roberto
    Rebecca, Vito W.
    Mills, Gordon
    Lu, Yiling
    Felipe da Silva, Aloisio Souza
    Lopes Consolaro, Marcia Edilaine
    Herlyn, Meenhard
    Possik, Patricia A.
    Goding, Colin R.
    Maria-Engler, Silvya Stuchi
    PHARMACOLOGICAL RESEARCH, 2021, 173
12345